polycystic ovary syndrome (PCOS)

October 2004

There's growing interest in polycystic ovary syndrome (PCOS).

It's the MOST common endocrine disorder in young women. It affects up to 10% of reproductive-age women.

These women usually have insulin resistance and evidence of increased androgens. This leads to irregular periods, infertility, obesity, and hirsutism.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

treating ADHD in ADULTS
Antiplatelets patients take BOTH aspirin and Plavix (clopidogrel)
Gastroenterology Zelnorm (tegaserod) is now approved for chronic constipation
Neurology & Pain Cymbalta for neuropathic pain
Neurology & Pain Neurontin is linked to suicides
Women's Health polycystic ovary syndrome (PCOS)
Supplements American ginseng and St. John's wort might DECREASE warfarin's anticoagulant effects
Supplements "cortisol blockers" for weight loss
Migraine Topamax (topiramate) is now approved to PREVENT migraines
Cholesterol "better" cholesterol tests
Pediatrics What is the best treatment for febrile seizures
increasing pressure for drug companies to register ALL their studies
Thyroid Disorders switch levothyroxine products

polycystic ovary syndrome (PCOS)

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents